UTHSC In the Media


Multiple COVID-19 vaccine/treatment trials underway in Memphis

In the Media Icon

St. Jude announced Friday they’re looking for 500 adult participants in a phase three clinical trial of a COVID-19 vaccine. Multiple trials for vaccines and therapies are underway in Memphis right now. St. Jude said a phase three clinical trial of a COVID-19 vaccine with Johnson & Johnson will take place on their campus. Participants… Read More


St. Jude, UTHSC looking for local participants in phase 3 of COVID-19 vaccine trial

In the Media Icon

Mid-South leaders in the medical community are searching for participants for the next phase of the COVID-19 vaccine trial. St. Jude Children’s Research Hospital and the University of Tennessee Health Science Center are offering a testing site for the Janssen Pharmaceutical Companies of Johnson & Johnson’s Phase 3 clinical research study, ENSEMBLE trial.  


$51M field hospital ready, but ‘there are not enough nurses’

In the Media Icon

For months, the $51 million remake of the former Commercial Appeal building has offered the unsettling reassurance that the region has a reservoir if the hospital system gets overwhelmed. On Thursday, leaders at the University of Tennessee Health Science Center, who will be in charge of running it, said they are worried about finding the… Read More


UT College of Dentistry Names Facilities After Delta Dental of Tennessee

In the Media Icon

The University of Tennessee (UT) Board of Trustees has approved a request from the UT Health Science Center (UTHSC) to name the new dental building under construction on the Memphis campus the Delta Dental of Tennessee Building.


St. Jude, UTHSC looking for local participants in phase 3 of COVID-19 vaccine trial

In the Media Icon

Mid-South leaders in the medical community are searching for participants for the next phase of the COVID-19 vaccine trial. St. Jude Children’s Research Hospital and the University of Tennessee Health Science Center are offering a testing site for the Janssen Pharmaceutical Companies of Johnson & Johnson’s Phase 3 clinical research study, ensemble trial, according to… Read More


UT Health Science Center researchers impressed by early participation in Regeneron COVID-19 treatment drug study

In the Media Icon

Doctors at University of Tennessee Health Science Center said their COVID-19 treatment study is already off to a better than expected and positive start.Researchers are seeing how well a COVID-19 treatment drug works with the area’s diverse population.


Mid-South doctor says if COVID-19 surge continues, Shelby Co. hospitals could be in trouble with flu season approaching

In the Media Icon

As cases rise across Shelby County there are questions about hospitalization rates and the use of beds in hospitals across the Mid-South. Dr. Jon McCullers, Chairman of the Department of Pediatrics at The University of Tennessee Health Science Center joined WMC Action News 5 Tuesday to talk about the coronavirus pandemic and how it’s impacting… Read More


Amazingly powerful’ UTHSC/Le Bonheur DNA initiative gets assist from Regeneron genetics platform

The Memphis Business Journal

 A local DNA biorepository initiative has grown into one of the largest in the world for children. And now, a partnership with a New York-based pharma firm shows potential in unlocking DNA for research — and, in the future, personalized medicine. In 2015, the University of Tennessee Health Science Center (UTHSC) and Le Bonheur Children’s… Read More